Scholarlink

Background <p>Diabetic vascular complications are major health concerns. MicroRNAs (miRNAs) are implicated in their pathogenesis. This study aimed to evaluate the abnormal expression of miR-503-5p in diabetic vascular complications and explore its regulatory mechanisms in diabetic retinopathy.</p> Methods <p>Studies on miR-503-5p expression in diabetic vascular complications were selected from PubMed, Embase, Web of Science, Cochrane, and Scopus databases. Experimental validation was carried out utilizing human retinal pigment epithelial cells (ARPE-19) that were subjected to a high glucose (HG) environment. miR-503-5p expression, cell proliferation, apoptosis, inflammatory cytokines, and oxidative stress markers were measured.</p> Results <p>The meta-analysis showed miR-503-5p was upregulated overall in diabetic vascular complications (SMD = 0.71, 95% CI: -2.21 to 3.64). Subgroup analysis showed that miR-503-5p expression was significantly increased in cell samples (SMD = 5.84, 95% CI: 2.40 to 9.27), and in major vascular complications (SMD = 2.89, 95% CI: 0.35 to 5.44). High miR-503-5p could distinguish diabetic retinopathy from healthy controls (AUC = 0.918, sensitivity = 81.2%, specificity = 92.7%). HG upregulated miR-503-5p in ARPE-19 cells. miR-503-5p inhibitor linked to increased proliferation, reduced apoptosis, and modulated inflammatory and oxidative stress responses.</p> Conclusions <p>MiR-503-5p was significantly upregulated in diabetic vascular complications, particularly in cell samples and major vascular complications. MiR-503-5p may serve as a diagnostic biomarker for diabetic retinopathy. The elevated levels of miR-503-5p in ARPE-19 cells under high glucose conditions were associated with increased inflammation, oxidative stress, and apoptosis, as well as decreased cell proliferation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Systematic validation of miR-503-5p abnormal expression in diabetic vascular complications: a meta-analysis and exploration of its targeted regulatory mechanism in retinopathy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月29日

查看全文
  • Mo Zhang,
  • Ping Shuai,
  • Xian Wang,
  • Yongli Lan,
  • Kangli Deng,
  • Yong Zeng

摘要

Background

Diabetic vascular complications are major health concerns. MicroRNAs (miRNAs) are implicated in their pathogenesis. This study aimed to evaluate the abnormal expression of miR-503-5p in diabetic vascular complications and explore its regulatory mechanisms in diabetic retinopathy.

Methods

Studies on miR-503-5p expression in diabetic vascular complications were selected from PubMed, Embase, Web of Science, Cochrane, and Scopus databases. Experimental validation was carried out utilizing human retinal pigment epithelial cells (ARPE-19) that were subjected to a high glucose (HG) environment. miR-503-5p expression, cell proliferation, apoptosis, inflammatory cytokines, and oxidative stress markers were measured.

Results

The meta-analysis showed miR-503-5p was upregulated overall in diabetic vascular complications (SMD = 0.71, 95% CI: -2.21 to 3.64). Subgroup analysis showed that miR-503-5p expression was significantly increased in cell samples (SMD = 5.84, 95% CI: 2.40 to 9.27), and in major vascular complications (SMD = 2.89, 95% CI: 0.35 to 5.44). High miR-503-5p could distinguish diabetic retinopathy from healthy controls (AUC = 0.918, sensitivity = 81.2%, specificity = 92.7%). HG upregulated miR-503-5p in ARPE-19 cells. miR-503-5p inhibitor linked to increased proliferation, reduced apoptosis, and modulated inflammatory and oxidative stress responses.

Conclusions

MiR-503-5p was significantly upregulated in diabetic vascular complications, particularly in cell samples and major vascular complications. MiR-503-5p may serve as a diagnostic biomarker for diabetic retinopathy. The elevated levels of miR-503-5p in ARPE-19 cells under high glucose conditions were associated with increased inflammation, oxidative stress, and apoptosis, as well as decreased cell proliferation.